UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Base-edited CAR T cells for combinational therapy against T cell malignancies

Leukemia, 2021-12, Vol.35 (12), p.3466-3481

2021

Volltextzugriff (PDF)

An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies

Leukemia, 2018-09, Vol.32 (9), p.1970-1983

2018

Volltextzugriff (PDF)

Chimeric antigen receptor T cells targeting CD7 in a child with high-risk T-cell acute lymphoblastic leukemia

International immunopharmacology, 2021-07, Vol.96, p.107731-107731, Article 107731

2021

Volltextzugriff (PDF)

Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia

The New England journal of medicine, 2023-09, Vol.389 (10), p.899-910

2023

Volltextzugriff (PDF)

CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies

Blood, 2017-07, Vol.130 (3), p.285-296

2017

Volltextzugriff (PDF)

The clinical importance of CD4+CD7− in human diseases

Journal of cellular physiology, 2019-02, Vol.234 (2), p.1179-1189

2019

Volltextzugriff (PDF)

CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia

Molecular therapy, 2019-01, Vol.27 (1), p.272-280

2019

Volltextzugriff (PDF)

Naturally selected CD7 CAR-T therapy without genetic editing demonstrates significant antitumour efficacy against relapsed and refractory acute myeloid leukaemia (R/R-AML)

Journal of translational medicine, 2022-12, Vol.20 (1), p.600-600, Article 600

2022

Volltextzugriff (PDF)

Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis

The New England journal of medicine, 2024-04, Vol.390 (16), p.1467-1480

2024

Volltextzugriff (PDF)

CD7 CAR T-Cell Therapy and Allogeneic HSCT

The New England journal of medicine, 2024-07, Vol.391 (1), p.92-93

Fuji, Shigeo

2024

Volltextzugriff (PDF)

Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia

Journal of hematology and oncology, 2023-04, Vol.16 (1), p.34-34, Article 34

2023

Volltextzugriff (PDF)

UM171 expands distinct types of myeloid and NK progenitors from human pluripotent stem cells

Scientific reports, 2019-04, Vol.9 (1), p.6622-6622, Article 6622

2019

Volltextzugriff (PDF)

A young woman with persistent sore throat, Epstein–Barr virus, lymphadenopathy, and aberrant CD4 + CD7‐ T‐cells

American journal of hematology, 2023-05, Vol.98 (5), p.824-829

2023

Volltextzugriff (PDF)

Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients

Experimental dermatology, 2024-09, Vol.33 (9), p.e15171-n/a

2024

Volltextzugriff (PDF)

CD7 is expressed on a subset of normal CD34‐positive myeloid precursors

European journal of haematology, 2018-09, Vol.101 (3), p.318-325

2018

Volltextzugriff (PDF)

Secreted and transmembrane 1A is a novel co-stimulatory ligand

PloS one, 2013-09, Vol.8 (9), p.e73610-e73610

2013

Volltextzugriff (PDF)

T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape

Signal transduction and targeted therapy, 2022-03, Vol.7 (1), p.85-12, Article 85

2022

Volltextzugriff (PDF)

The CD3 versus CD7 plot in multicolor flow cytometry reflects progression of disease stage in patients infected with HTLV-I

PloS one, 2013-01, Vol.8 (1), p.e53728-e53728

2013

Volltextzugriff (PDF)

Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Haematologica (Roma), 2015-04, Vol.100 (4), p.472-478

2015

Volltextzugriff (PDF)

Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes

Cytometry. Part B, Clinical cytometry, 2021-05, Vol.100 (3), p.312-321

2021

Volltextzugriff (PDF)

FLT3‐ITD DNA and mRNA levels in AML do not correlate with CD7, CD33 and CD123 expression

Journal of cellular and molecular medicine, 2020-07, Vol.24 (13), p.7675-7679

2020

Volltextzugriff (PDF)

CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis

Cancer research (Chicago, Ill.), 2003-12, Vol.63 (23), p.8302-8311

2003

Volltextzugriff (PDF)

Die Wirkung von Mogamulizumab auf die aberrante T‐Zell‐Population im peripheren Blut – eine monozentrische retrospektive Analyse

Journal der Deutschen Dermatologischen Gesellschaft, 2023-09, Vol.21 (9), p.992-1002

2023

Volltextzugriff (PDF)

Mortalität, prognostische Parameter und Behandlungsstrategien bei Mycosis fungoides

Journal der Deutschen Dermatologischen Gesellschaft, 2024-04, Vol.22 (4), p.532-552

2024

Volltextzugriff (PDF)

Immunophenotypic analysis of cerebrospinal fluid reveals concurrent development of ATL in the CNS of a HAM/TSP patient

International journal of hematology, 2020-06, Vol.111 (6), p.891-896

2020

Volltextzugriff (PDF)

1 – 25 von 898

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(807)
Mit Volltextzugriff
(726)

Publikationsform

Artikel
(897)
Buchkapitel
(1)

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(721)
Science & Technology
(691)
Life Sciences & Biomedicine
(670)
Cd7 Antigen
(332)
Male
(321)
Biological And Medical Sciences
(295)
Female
(279)
Hematology
(260)
Adult
(240)
Flow Cytometry
(235)
Medical Sciences
(233)
Middle Aged
(224)
Immunophenotyping
(206)
Oncology
(204)
Antigens, Cd7
(203)
Aged
(170)
Leukemia
(170)
Lymphocytes T
(163)
Hematologic And Hematopoietic Diseases
(153)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(141)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Base-edited CAR T cells for combinational therapy against T cell malignancies

An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies

Chimeric antigen receptor T cells targeting CD7 in a child with high-risk T-cell acute lymphoblastic leukemia

Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia

CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies

The clinical importance of CD4+CD7− in human diseases

CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia

Naturally selected CD7 CAR-T therapy without genetic editing demonstrates significant antitumour efficacy against relapsed and refractory acute myeloid leukaemia (R/R-AML)

Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis

CD7 CAR T-Cell Therapy and Allogeneic HSCT

Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia

UM171 expands distinct types of myeloid and NK progenitors from human pluripotent stem cells

A young woman with persistent sore throat, Epstein–Barr virus, lymphadenopathy, and aberrant CD4 + CD7‐ T‐cells

Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients

CD7 is expressed on a subset of normal CD34‐positive myeloid precursors

Secreted and transmembrane 1A is a novel co-stimulatory ligand

T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape

The CD3 versus CD7 plot in multicolor flow cytometry reflects progression of disease stage in patients infected with HTLV-I

Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes

FLT3‐ITD DNA and mRNA levels in AML do not correlate with CD7, CD33 and CD123 expression

CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis

Die Wirkung von Mogamulizumab auf die aberrante T‐Zell‐Population im peripheren Blut – eine monozentrische retrospektive Analyse

Mortalität, prognostische Parameter und Behandlungsstrategien bei Mycosis fungoides

Immunophenotypic analysis of cerebrospinal fluid reveals concurrent development of ATL in the CNS of a HAM/TSP patient

Suchergebnisse filtern